• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medical outcome trials: data-driven execution ensures success

Medical outcome trials: data-driven execution ensures success

April 15, 2015
CenterWatch Staff

Second of two parts

Successful delivery of medical outcome trials involves signifi­cant pre-planning to ensure the right strategy for conducting trials. A simple, direct protocol designed to answer the right question for all stakeholders and with targeted data that are easy to interpret is a corner­stone of success. Effective operational delivery depends on a critical combi­nation of ‘right path, right start and right patients’ in advance of trial ex­ecution.

The right path involves develop­ing appropriate country and site se­lection strategies based on targeted investigators, launch timing, regu­latory approval timelines, protocol suitability and medical management of subjects. A feasibility assessment to determine countries and sites with adequate patient population and ac­ceptable clinical trial performance and experience facilitates the start-up process and promotes meeting enrollment timelines and overall site performance. An integrated site model can simplify these intricate interdependencies and synchronize regulatory and ethics filings. In ad­dition, the monitoring methodology must be consistent with the protocol, designed to be as cost-sensitive as possible and implementing a com­bination of on-site and remote visits.

The right start depends on deter­mining realistic timelines for the first Site Initiation Visit in each country, developing a plan for recommended efficiencies, setting up templates and processes as soon as the trial is awarded, engaging sites early and maintaining their engagement.

Recruiting the right patients re­quires strategies for pre-identification of qualified patients, final strategy including direct-to-patient contacts, and materials development to both inform patients about the therapeu­tic area and maintain patient motiva­tion and participation. Considering the patients’ trial obligations has a direct impact on both recruitment and retention. Obtaining Informed Consent for direct patient contacts is essential.

Data-driven, evidence-based de­cision making can avoid unforeseen challenges with medical outcome tri­als. Proactive study planning across the trial continuum, beginning with the end in mind, is a proven and highly effective strategy for trial ex­ecution success.

 

Written by Guest Writer Patricia Steigerwald, MS, RN. Steigerwald is vice president, regional managing director of the Americas for Quintiles Real World Late Phase, providing strategic and operational oversight to ensure fit-for-purpose operational delivery of quality data, patient safety and regulatory adherence. She has nearly 30 years of clinical research experience, with more than 15 years in development and delivery of regulatory-compliant strategies for the conduct of real-world and late-phase programs across all therapeutic areas.

This article was reprinted from Volume 22, Issue 04, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing